Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 156,079 229,843 273,203 611,547
Total Sell Value $13,472,349 $20,340,408 $24,241,430 $58,103,504
Total People Sold 5 5 6 7
Total Sell Transactions 13 19 25 55
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 1303
  Page 40 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baffi Robert SVP, Technial Operations   •       –      –    2008-10-31 5 B $13.35 $3,058 D/D 229 14,000     -
   Aselage Steve SVP, Global Commercial Dev   •       –      –    2008-10-31 5 B $13.35 $16,506 D/D 1,236 32,401     -
   Davis George Eric VP, General Counsel   •       –      –    2008-10-31 4 B $13.35 $2,484 D/D 186 15,180 2.66     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2008-10-31 4 AB $13.35 $4,233 D/D 317 115,621     -
   Wood Mark VP, Human Resources   •       –      –    2008-10-21 4 AS $20.22 $3,579 D/D (177) 650     -
   Wood Mark VP, Human Resources   •       –      –    2008-10-21 4 OE $6.13 $1,085 D/D 177 827     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2008-10-01 4 AS $26.27 $472,878 D/D (18,000) 115,304     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2008-10-01 4 OE $6.13 $110,340 D/D 18,000 133,304     -
   Wood Mark VP, Human Resources   •       –      –    2008-09-22 4 AS $27.85 $69,178 D/D (2,468) 650     -
   Wood Mark VP, Human Resources   •       –      –    2008-09-22 4 OE $6.13 $37,012 D/D 2,468 3,118     -
   Baffi Robert SVP, Technical Operations   •       –      –    2008-09-02 4 AS $31.31 $360,965 D/D (11,528) 38,434     -
   Baffi Robert SVP, Technical Operations   •       –      –    2008-09-02 4 OE $22.00 $253,616 D/D 11,528 49,962     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2008-09-02 4 AS $30.19 $543,384 D/D (18,000) 115,304     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2008-09-02 4 OE $6.13 $36,780 D/D 6,000 133,304     -
   Wood Mark VP, Human Resources   •       –      –    2008-08-21 4 AS $26.10 $64,436 D/D (2,469) 650     -
   Wood Mark VP, Human Resources   •       –      –    2008-08-21 4 OE $6.13 $37,031 D/D 2,469 3,119     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2008-08-11 4 OE $6.46 $3,876 D/D 600 10,917     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2008-08-08 4 OE $6.46 $4,199 D/D 650 10,317     -
   Bienaime Jean Jacques Chief Executive Office   •       •      –    2008-08-07 4 OE $6.46 $3,230 D/D 500 9,667     -
   Bienaime Jean Jacques Chief Executive Office   •       •      –    2008-08-06 4 OE $6.46 $3,876 D/D 600 9,167     -
   Kakkis Emil D Chief Medical Officer   •       –      –    2008-08-01 4 AS $32.34 $584,578 D/D (18,000) 127,304     -
   Baffi Robert SVP, Technical Operations   •       –      –    2008-07-30 4 AS $31.91 $329,430 D/D (10,300) 38,434     -
   Baffi Robert SVP, Technical Operations   •       –      –    2008-07-30 4 AS $31.04 $292,432 D/D (9,228) 48,734     -
   Baffi Robert SVP, Technical Operations   •       –      –    2008-07-30 4 OE $22.00 $429,616 D/D 19,528 57,962     -
   Wood Mark VP, Human Resources   •       –      –    2008-07-21 4 AS $30.10 $74,695 D/D (2,468) 650     -
  1303 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 40 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us